Lunasin: A novel cancer preventive seed peptide

Perspectives in Medicinal Chemistry

Volumn 2008, Issue 2, 2008, Pages 75-80

  Hernández Ledesma, Blanca ^a   de Lumen, Ben O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer prevention; Lunasin; Seeds; Soy protein

Indexed keywords

ISOFLAVONE; LUNASIN; PROTEINASE INHIBITOR; SOYBEAN PROTEIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; BARLEY; CANCER MORTALITY; CANCER PREVENTION; DRUG STRUCTURE; EPIGENETICS; IN VITRO STUDY; IN VIVO STUDY; LIFESTYLE MODIFICATION; MOUSE; NONHUMAN; NUTRITIONAL HEALTH; PAPILLOMA; PHARMACOGENETICS; PHYTOCHEMISTRY; REVIEW; SKIN TUMOR; SOYBEAN; WESTERN HEMISPHERE; WHEAT;

EID: 77953381344     PISSN: None     EISSN: 1177391X     Source Type: Journal    
DOI: 10.4137/pmc.s372     Document Type: Review

References (40)

1. Armstrong, W.B., Kennedy,A.R., Wan, X.S. et al. 2000. Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia. Cancer Epidemiol. Biomarkers Prev, 9:43-7.
2. Armstrong, W.B., Wan, X.S., Kennedy, A.R. et al. 2003. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment. Laryngoscope, 113:1687-702.
3. Billings, P.C. and Habres, J.M. 1992. A growth-regulated protease activity that is inhibited by the anticarcinogenic Bowman-Birk protease inhibitor. Proc. Natl. Acad. Sci. US.A., 89:3120-4.
4. Dai, Q., Franke, A.A., Jin, F. et al. 2002. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol. Biomarkers Prev., 11:815-21.
5. de Lumen, B.O. 2005. Lunasin: a cancer-preventive soy peptide. Nutr. Rev., 63:16-21.
6. Evans, S.M., von Winkle, T., Szuhaj, B. et al. 1992. Protection against metastasis of radiation-induced thymic lymphosarcoma and weightloss in C57BL/6NCR1BR mice by an autoclave-resistant factor present in soybeans. Radiat. Res., 132:259-62.
7. Galvez, A.F., Chen, N., Macasieb, J. et al. 2001. Chemopreventive property of a soybean peptide (Lunasin) that binds to deacetylated histones and inhibit acetylation. Cancer Res., 61:7473-8.
8. Galvez, A.F. and de Lumen, B.O. 1999. A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis in mammalian cells. Nat. Biotechnol., 17:495-500.
9. Galvez, A.F., Revilleza, M.J.R. and de Lumen, B.O. 1997. A novel methionine-rich protein from soybean cotyledon: cloning and characeterization of cDNA (accession No. AF005030). Plant Register #PGR97-103. Plant Physiol., 114:1567-9.
10. Gonzalez de Mejia, E., Vasconez, M., de Lumen, B.O. et al. 2004. Lunasin concentration in different soybean genotypes, commercial soy protein, and isoflavone products. J. Agric. Food Chem., 52:5882-7.
11. Goodman, M.T., Wilkens, L.R., Hankin, J.H. et al. 1997. Association of soy and fiber consumption with the risk of endometrial cancer. Am. J. Epidemiol., 146:294-306.
12. 2O labeling: a sensitive marker of epidermal proliferation state. J. Invest. Dermatol., 123:530-6.
13. Jacobsen, B.K., Knutsen, S.F. and Fraser, G.E. 1998. Does high soy milk intake reduce prostate cancer incidence? The Adventist health study (United States). Cancer Causes Control, 9:553-7.
14. Jeong, H.J., Lam, Y. and, de Lumen, B.O. 2002. Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells. J. Agric. Food Chem., 50:5903-8.
15. Jeong, H.J., Park, J.H., Lam, Y. et al. 2003. Characterization of lunasin isolated from soybean. J. Agric. Food Chem., 51:7901-6.
16. Jeong, H.J., Jeong, J.B., Kim, D.S et al. 26007a. Inhibition of core histone acetylation by the cancer preventive peptide Lunasin. J. Agric. Food Chem., 55:632-7.
17. Jeong, H.J., Jeong, J.B., Kim, D.S. et al. 2007b. The cancer preventive peptide lunasin from wheat inhibits core histone acetylation. Cancer Lett, 255:42-8.
18. Jeong, J.B., Jeong, H.J., Park, J.H. et al. 2007c. Cancer-preventive peptide lunasin from Solanum nigrum L. inhibits acetylation of core histones H3 and H4 and phosphorylation of retinobalstoma protein (Rb). J. Agric. Food Chem., 5:107407-13.
19. Kennedy, A.R. 1994. Prevention of carcinogenesis by protease inhibitors. Cancer Res., 4:S1999-S2005.
20. Kennedy, A.R. 1998a. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. Am. J. Clin. Nutr., 68:1406S-12S.
21. Kennedy, A.R. 1998b. Chemopreventive agents: Protease inhibitors. Pharmacol. Therapeut., 78:167-209.
22. Kennedy, A.R. and Wan, X.S. 2002. Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells. Prostate, 50:125-33.
23. Kennedy, A.R., Beazer-Barclay, Y., Kinzier, K.W. et al. 1996. Suppression of carcinogenesis in the intestines of min mice by the soybean-derived Bowman-Birk inhibitor. Cancer Res., 56:679-82.
24. Kennedy, A.R., Billings, P.C., Wan, S. et al. 2002. Effects of Bowman-Birk inhibitor on rat colon carcinogenesis. Nutr. Cancer, 43:174-86.
25. Lam, Y., Galvez, A. and de Lumen, B.O. 2003. Lunasin suppresses ElA-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines. Nutr Cancer, 47:88-94.
26. Lee, M.M., Gomez, S.L., Chang, J.S. et al. 2003. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol. Biomarkers Prev., 12:665-8.
27. McCue, P. and Shetty, K. 2004. Health benefits of soy isoflavonoids and strategies for enhancement: a review. Crit. Rev. Food Sci. Nutr., 44:361-7.
28. Messadi, D.V., Billings, P., Shklar, G. et al. 1986. Inhibition of oral carcinogenesis by a protease inhibitor. J. Natl. Cancer Inst., 76:447-52.
29. Messina, M. and Barnes, S. 1991. The role of soy products in reducing the risk of cancer. J. Natl. Cancer Inst., 83:541-6.
30. Meyskens, F.L. 2001. Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer. Ann. NY Acad. Sci., 952:116-23.
31. Park, J.H., Jeong, H.J. and de Lumen, B.O. 2005. Contents and bioactivities of Lunasin, Bowman-Birk inhibitor, and isoflavones in soybean seed. J. Agric. Food Chem., 53:7686-90.
32. Pollard, M. and Wolter, W. 2000. Prevention of spontaneous prostate-related cancer in Lobund-Wistars rats by a soy protein isolate/ isoflavone diet. Prostate, 45:101-5.
33. Silva-Sánchez, C., Barba de la Rosa, A.P., León-Galvin, M.F. et al. 2008. Bioactivc peptides in amaranth (Amaranthus hypochondriacus) seed. J. Agric. Food Chem., 56:1233-40.
34. St. Clair, W.H., Billings, P.C., Carew, A.J. et al. 1990. Suppression of dimethylhydrazine-induced carcinogenesis in mice by dietary addition of the Bowman-Birk protease inhibitor. Cancer Res., 50:580-6.
35. von Hofe, E., Newberne, P.M. and Kennedy, A.R. 1991. Inhibition of N-nitrosomethylbenzylamine-induced esophageal neoplasms by the Bowman-Birk protease inhibitor. Carcinogenesis, 12:2147-50.
36. Witschi, H. and Kennedy, A.R. 1989. Modulation of lung-tumor development in mice with the soybean-derived Bowman-Birk protease inhibitor. Carcinogenesis, 10:2275-7.
37. Wu, A.H., Ziegler, R.G., Nomura, A.M. et al. 1998. Soy intake and risk of breast cancer in Asian and Asian-Americans. Am. J. Clin. Nutr., 68(suppl 6):1437S-44S.
38. Yamamoto, S., Sobue, T., Kobayashi, M. et al. 2003. Soy, isoflavones, and breast cancer risk in Japan. J. Natl. Cancer Inst., 95:906-13.
39. Yavelow, J., Collins, M., Birk, Y. et al. 1985. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress X-ray induced transformation in vitro. Proc. Natl. Acad. Sci. USA., 82:5395-9.
40. Zhang, L.L., Wan, X.S., Donahue, J.J. et al. 1999. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells. Nutr. Cancer, 33:165-73.